These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


276 related items for PubMed ID: 8774759

  • 21. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N, Kuro T, Fujita K, Azuma S, Matsumura Y.
    Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
    [Abstract] [Full Text] [Related]

  • 22. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
    Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM.
    Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
    [Abstract] [Full Text] [Related]

  • 23. Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, Oka N, Tanaka T.
    Biol Pharm Bull; 1995 Jul; 18(7):1016-9. PubMed ID: 7581242
    [Abstract] [Full Text] [Related]

  • 24. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T, Okahara A, Nose M, Ikuse T, Matsumura Y.
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats.
    David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Rebouças NA, Tostes RC.
    Hypertension; 2001 Sep; 38(3 Pt 2):692-6. PubMed ID: 11566958
    [Abstract] [Full Text] [Related]

  • 33. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ, Fink GD, Watts SW, Galligan JJ.
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [Abstract] [Full Text] [Related]

  • 34. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
    Intengan HD, He G, Schiffrin EL.
    Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
    [Abstract] [Full Text] [Related]

  • 35. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Pu Q, Touyz RM, Schiffrin EL.
    J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
    [Abstract] [Full Text] [Related]

  • 36. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH, Venema RC, Pollock DM.
    Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A, Fenning A, Levick S, Hoey A, Brown L.
    Br J Pharmacol; 2005 Nov; 146(6):846-53. PubMed ID: 16151437
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.